Mortality in cerebral venous thrombosis: results from the national inpatient sample database
- PMID: 23428995
- DOI: 10.1159/000343653
Mortality in cerebral venous thrombosis: results from the national inpatient sample database
Abstract
Background: Outcomes of cerebral venous thrombosis (CVT) vary from full recovery to death. Few studies have been performed examining epidemiologic and medical risk factors associated with high mortality in CVT. In this study, we examined the National Inpatient Sample (NIS) to determine the epidemiologic and medical risk factors associated with increased mortality from CVT.
Materials and methods: Using the NIS from 2001 to 2008, patients who suffered from CVT were identified using the ICD-9 codes 437.6 (nonpyogenic thrombosis of intracranial venous sinus), 325 (phlebitis and thrombophlebitis of intracranial venous sinuses) and 671.5 (peripartum phlebitis and thrombosis, cerebral venous thrombosis, thrombosis of intracranial venous sinus). We analyzed the associations of demographic factors, risk factors, comorbidities, complications of CVT, and therapeutic interventions with in-hospital mortality. We performed a multivariate logistic regression analysis to determine which variables were independently associated with in-hospital mortality.
Results: 11,400 patients were hospitalized with CVT between 2001 and 2008. Two-hundred and thirty-two (2.0%) suffered in-hospital mortality. Patients 15-49 years old had the lowest mortality rate (1.5%) compared with 2.8% for patients aged 50-64 (p < 0.001) and 6.1% for patients ≥65 years old (p < 0.001). The most common condition associated with CVT was pregnancy/puerperium (24.6%), and these women had a low mortality rate (0.4%). On multivariate analysis, the comorbidity most strongly associated with increased risk of mortality was sepsis (mortality rate 15.6%, OR = 7.5, 95% CI = 4.79-11.53, p < 0.001). Malignancy, underlying autoimmune disease and substance abuse were also independently associated with mortality, but with lower mortality rates (<5%). Complications associated with increased risk of mortality included paralysis (8.0%, OR = 3.4, 95% CI = 3.17-6.96, p < 0.001), intracranial hemorrhage (8.7%, OR = 5.4, 95% CI = 4.38-7.96, p < 0.001), and hydrocephalus (15.0%, OR = 3.2, 95% CI = 5.54-15.11, p = 0.004). Demographic variables associated with decreased mortality on multivariate analysis were male gender (2.1%, OR = 0.62, 95% CI = 0.43-0.87, p = 0.006) and Asian/Pacific Islander race (OR = 0.00, 95% CI = 0-0.27, p < 001).
Conclusions: CVT is associated with a low in-hospital mortality rate. Amongst patients suffering CVT, male gender and Asian/Pacific Islander race were independently associated with lower odds of in-hospital mortality when compared to their female and white counterparts, respectively. Septic patients with CVT have the greatest risk of in-hospital mortality. Hydrocephalus, intracranial hemorrhage, and motor deficits are also associated with higher risk of death. Our results build on previous evidence that serves to define a group of patients with CVT at high risk of early death.
Copyright © 2013 S. Karger AG, Basel.
Similar articles
-
Predictors of hospital outcome in patients with cerebral venous thrombosis.J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2725-2729. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.020. Epub 2014 Oct 11. J Stroke Cerebrovasc Dis. 2014. PMID: 25307433
-
Predictors of cerebral venous thrombosis and arterial ischemic stroke in young Asian women.J Stroke Cerebrovasc Dis. 2012 Nov;21(8):689-94. doi: 10.1016/j.jstrokecerebrovasdis.2011.03.002. Epub 2011 Apr 20. J Stroke Cerebrovasc Dis. 2012. PMID: 21511496
-
Cerebral venous thrombosis in Argentina: clinical presentation, predisposing factors, outcomes and literature review.J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105145. doi: 10.1016/j.jstrokecerebrovasdis.2020.105145. Epub 2020 Jul 28. J Stroke Cerebrovasc Dis. 2020. PMID: 32912503 Review.
-
Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study.Stroke. 2021 Nov;52(11):3578-3585. doi: 10.1161/STROKEAHA.121.034202. Epub 2021 Aug 10. Stroke. 2021. PMID: 34372672 Free PMC article.
-
Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review.Cerebrovasc Dis. 2014;37(1):43-50. doi: 10.1159/000356840. Epub 2013 Dec 18. Cerebrovasc Dis. 2014. PMID: 24356180 Review.
Cited by
-
The Burden of Cerebral Venous Thrombosis in a Romanian Population across a 5-Year Period.Life (Basel). 2022 Nov 9;12(11):1825. doi: 10.3390/life12111825. Life (Basel). 2022. PMID: 36362980 Free PMC article.
-
Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach.Ther Adv Neurol Disord. 2022 Jun 28;15:17562864221106362. doi: 10.1177/17562864221106362. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35785404 Free PMC article. Review.
-
Diabetic ketoacidosis, cerebral venous sinus thrombosis and fulminant cerebral oedema in COVID-19 infection complicated by Klebsiella pneumoniae infection.BMJ Case Rep. 2022 Apr 4;15(4):e248046. doi: 10.1136/bcr-2021-248046. BMJ Case Rep. 2022. PMID: 35379681 Free PMC article.
-
Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review.J Prim Care Community Health. 2022 Jan-Dec;13:21501319221074450. doi: 10.1177/21501319221074450. J Prim Care Community Health. 2022. PMID: 35142234 Free PMC article.
-
Analyzing the Effects of Demographic Differences on Patient Outcomes Following Non-pyogenic Intracranial Venous Thrombosis.Cureus. 2021 Nov 19;13(11):e19753. doi: 10.7759/cureus.19753. eCollection 2021 Nov. Cureus. 2021. PMID: 34938630 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
